3-NONANON-1-OL
General Information
Mainterm | 3-NONANON-1-OL |
Doc Type | NIL |
CAS Reg.No.(or other ID) | 67801-46-1 |
Regnum |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 5362570 |
IUPAC Name | 1-hydroxynonan-3-one |
InChI | InChI=1S/C9H18O2/c1-2-3-4-5-6-9(11)7-8-10/h10H,2-8H2,1H3 |
InChI Key | KCTDZLVBGWXNSQ-UHFFFAOYSA-N |
Canonical SMILES | CCCCCCC(=O)CCO |
Molecular Formula | C9H18O2 |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 158.241 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 7 |
Complexity | 99.7 |
CACTVS Substructure Key Fingerprint | A A A D c e B w M A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A C A A A C A S g g A I C A A A A A g A I A I A Q A A A A A A A A A A A A A A E A A A A A E B Y A A A A A Q A A E I A A A A A G I y K C A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 37.3 |
Monoisotopic Mass | 158.131 |
Exact Mass | 158.131 |
XLogP3 | None |
XLogP3-AA | 1.6 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 11 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9640 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.7406 |
P-glycoprotein Substrate | Non-substrate | 0.6206 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8770 |
Non-inhibitor | 0.7181 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8563 |
Distribution | ||
Subcellular localization | Mitochondria | 0.5658 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8038 |
CYP450 2D6 Substrate | Non-substrate | 0.8586 |
CYP450 3A4 Substrate | Non-substrate | 0.6645 |
CYP450 1A2 Inhibitor | Inhibitor | 0.5606 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8876 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8771 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8833 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9252 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8968 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8718 |
Non-inhibitor | 0.7594 | |
AMES Toxicity | Non AMES toxic | 0.9711 |
Carcinogens | Carcinogens | 0.5000 |
Fish Toxicity | High FHMT | 0.5571 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8951 |
Honey Bee Toxicity | High HBT | 0.6793 |
Biodegradation | Ready biodegradable | 0.9703 |
Acute Oral Toxicity | III | 0.5593 |
Carcinogenicity (Three-class) | Non-required | 0.7390 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -1.2792 | LogS |
Caco-2 Permeability | 1.4156 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.3355 | LD50, mol/kg |
Fish Toxicity | 2.0877 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.7575 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Lipids and lipid-like molecules |
Class | Fatty Acyls |
Subclass | Fatty alcohols |
Intermediate Tree Nodes | Not available |
Direct Parent | Fatty alcohols |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Fatty alcohol - Beta-hydroxy ketone - Ketone - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Primary alcohol - Organooxygen compound - Carbonyl group - Alcohol - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as fatty alcohols. These are aliphatic alcohols consisting of a chain of a least six carbon atoms. |
From ClassyFire